Contact us: 01476 247 007
How can we help
Pharmacovigilance
National contact person for pharmacovigilance – post Brexit
Pharmacovigilance Standard Operating Procedure Audits
Post Marketing Pharmacovigilance Support
Clinical Trial Pharmacovigilance Support
EU QPPV Provision
Quality & Compliance
Risk Assessment and Management
Signal Detection and Management
Medical Writing
Patient Information
Regulatory
Market Authorisation Holding
Brexit
Our Partners
Marti Farm
Affiliates
Medilink
External Team
News
Get in touch
✕
Filter by
Categories
Tags
Authors
Show all
All
Brexit Updates
Industry News
NCPP
Patient Information
PDS News
Pharmacovigilance
Risk Management
All
Aimovig
BioCity
brexit ready
Brexit updates
British Association for the Study of Headache
CGRP
chronic migraine
coronavirus
COVID-19
Deputy QPPV for Pharmacovigilance
EMA latest guidance
erenumab
EU MA
EU QPPV
EU QPPV for Pharmacovigilance
EU/EEA QPPV
European Marketing Authorisation Holders (MAH)
GCP inspections
Good Clinical Practice inspections
MAH Service
Marketing Authorisation Holders
medilink east midlands business awards
MHRA latest guidance
MHRA post-transition period information
National Contact Person for Pharmacovigilance (NCPP)
NICE agrees to look again at Novartis’ Aimovig for migraine prevention
Novartis
Outstanding Achievement Award
Periodic Safety Update Reports
Pharmaceutical administration services
pharmacovigilance
Pharmacovigilance (QPPV)
Pharmacovigilance (QPPV) provision post-Brexit
Post-Authorisation Safety Studies-protocols and final study reports
PSMF (pharmacovigilance system master file)
Pure Drug Safety
QPPV (Qualified Person for Pharmacovigilance)
QPPVs based in the UK
Quality and compliance
Regulatory services
remain compliant in the UK
Responsible Person for Eudravigilance in clinical trials
Risk Management Plans
severe migraine
summer intern
Sygnature Discovery
the transition period for Pharmacovigilance and Regulatory
UK and non-UK Individual Case Safety Reports
UK QPPV
All
bone
Liselle Barnsley
16th July 2021
16th July 2021
The Wire – read the latest news from PDS
Read the latest news from Pure Drug Safety in The Wire. Click here to start reading now.
8th July 2021
8th July 2021
How the Pandemic has changed things at PDS – we have moved
Like so many companies, here at PDS we had to change the way we worked from the first lockdown in March 2020. Fortunately for us, this
[…]
5th March 2021
5th March 2021
How the pandemic has reshaped the way we work at PDS
Here at PDS we work very closely as a team, both at work and socially. So when we had to quickly adapt to remote working during
[…]
21st December 2020
21st December 2020
Merry Christmas from us all at PDS!
Here at PDS, we wanted to wish all of our clients and colleagues a very Happy Christmas and here’s hoping for a better 2021 for everyone!
[…]
23rd October 2020
23rd October 2020
Summer internships at Pure Drug Safety
Life as a summer intern at Pure Drug Safety in 2020 was pretty different from previous years, as you might expect! With many business cancelling their
[…]
16th September 2020
16th September 2020
What’s it like to work at Pure Drug Safety – Rose’s view
We had the pleasure of welcoming two interns to work with us this summer at Pure Drug Safety. However, with the onset of the coronavirus pandemic,
[…]
16th September 2020
16th September 2020
What’s it like to work at Pure Drug Safety – Lottie’s view
We had the pleasure of welcoming two interns to work with us this summer at Pure Drug Safety. However, with the onset of the coronavirus pandemic,
[…]
15th May 2020
15th May 2020
Business as usual at Pure Drug Safety
We just wanted to reach out to say hello and let you know that we’re thinking of you as we enter another phase of change due
[…]
13th March 2020
13th March 2020
Coronavirus / COVID-19 – business as usual at PDS
We wanted to assure you that it’s business as usual here at PDS during the current coronavirus crisis. We are following the guidance offered by HM
[…]
1
2
Next page